Home People in the News New CEO named for SHINE Technologies’ industrial imaging arm

New CEO named for SHINE Technologies’ industrial imaging arm

Tom D'Orazio

Janesville-based Illuminated Holdings Inc., the parent company of SHINE Technologies, has named Tom D’Orazio as CEO of Phoenix LLC. Both SHINE Technologies and Phoenix are owned by Illuminated Holdings and Phoenix operates as the industrial imaging arm of the business. D’Orazio succeeds Jess Giffey, who served as interim CEO and will continue in her role

Already a subscriber? Log in

To continue reading this article ...

Subscribe to BizTimes today and get immediate access to our Insider-only content and much more.

Learn More and Subscribe Now
Ashley covers startups, technology and manufacturing for BizTimes. She was previously the managing editor of the News Graphic and Washington County Daily News. In past reporting roles, covering education at The Waukesha Freeman, she received several WNA awards. She is a UWM graduate. In her free time, Ashley enjoys watching independent films, tackling a new recipe in the kitchen and reading a good book.
Janesville-based Illuminated Holdings Inc., the parent company of SHINE Technologies, has named Tom D’Orazio as CEO of Phoenix LLC. Both SHINE Technologies and Phoenix are owned by Illuminated Holdings and Phoenix operates as the industrial imaging arm of the business. D'Orazio succeeds Jess Giffey, who served as interim CEO and will continue in her role as general manager of SHINE's Systems & Manufacturing division. "As a proven leader for science-driven companies, Tom will be a great addition to Phoenix," said Greg Piefer, founder and CEO of SHINE Technologies. "Along with the announcement of a contract with the Department of Homeland Security earlier this year, Phoenix has signed several new imaging contracts this year. With his leadership and experience, Tom will continue to build on that momentum. I'd also like to thank Jess for serving as interim CEO for the past year." D'Orazio has over two decades of experience in sales leadership roles for start-ups, emerging businesses and established companies across health care, biotech and software industries. He most recently was the chief operating officer for Tryp Therapeutics, a clinical-stage pharma company, where he was also a founding member. Prior to Tryp, he was CEO and president at ImmnoPrecise Antibodies, a scientific services and research organization. "I'm delighted to be back in Wisconsin and working on growing an innovative service enterprise," D'Orazio said. "The advanced technology and opportunity to help create a safer world through neutron imaging is both inspiring and exciting. I'm anxious to meet the talented team and get to work."

Stay up-to-date with our free email newsletter

Keep up with the issues, companies and people that matter most to business in the Milwaukee metro area.

By subscribing you agree to our privacy policy.

No, thank you.
Exit mobile version